Jacinto Convit | Academic Influence

Jacinto Convit's AcademicInfluence.com Rankings

Jacinto Convit

Philosophy

#2050

World Rank

#3583

Historical Rank

Logic

#6885

World Rank

#8443

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Jacinto Convit's Degrees

Doctorate Medicine Central University of Venezuela

Why Is Jacinto Convit Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jacinto Convit García was a Venezuelan physician and scientist, known for developing a vaccine to prevent leprosy and his studies to treat cancer. He played a role in founding Venezuela's National Institute of Biomedicine and held many leprosy-related positions. Among Convit's many honors for his work on leprosy and tropical diseases was Spain's Prince of Asturias Award in the Scientific and Technical Research category and France's Legion of Honor. In 1988, Convit was nominated for a Nobel Prize in Medicine for his experimental anti-leprosy vaccine.

(See a Problem?)

Jacinto Convit's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. (1991) (1114)
Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis (1995) (489)
Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid (1984) (203)
Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction (1993) (200)
Learning from lesions: patterns of tissue inflammation in leprosy. (1988) (192)
The clinical and immunological spectrum of American cutaneous leishmaniasis. (1993) (189)
Diffuse cutaneous leishmaniasis: a disease due to an immunological defect of the host. (1972) (189)
IMMUNOTHERAPY VERSUS CHEMOTHERAPY IN LOCALISED CUTANEOUS LEISHMANIASIS (1987) (170)
Diagnosis of cutaneous leishmaniasis and species discrimination of parasites by PCR and hybridization (1994) (146)
A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein (1992) (146)
Inhibition of leucocytic lysosomal enzymes by glycosaminoglycans in vitro. (1975) (120)
Immunoprophylactic trial with combined Mycobacterium Leprae/BCG vaccine against leprosy: preliminary results (1992) (109)
Immunological suppression by human CD8+ T cells is receptor dependent and HLA-DQ restricted. (1991) (107)
Immunotherapy of localized, intermediate, and diffuse forms of American cutaneous leishmaniasis. (1989) (101)
Organ-specific immunity in canine visceral leishmaniasis: analysis of symptomatic and asymptomatic dogs naturally infected with Leishmania chagasi. (2004) (92)
Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses (2007) (89)
Activated suppressor T cells in leprosy. (1982) (83)
In situ characterization of the cellular immune response in American cutaneous leishmaniasis. (1985) (83)
Immunotherapy of american cutaneous leishmaniasis in Venezuela during the period 1990-99. (2003) (80)
Immunotherapy with a mixture of Mycobacterium leprae and BCG in different forms of leprosy and in Mitsuda-negative contacts. (1982) (77)
HLA-linked control of predisposition to lepromatous leprosy. (1985) (76)
Therapy of Venezuelan patients with severe mucocutaneous or early lesions of diffuse cutaneous leishmaniasis with a vaccine containing pasteurized Leishmania promastigotes and bacillus Calmette-Guerin: preliminary report. (2004) (74)
Defect of in vitro digestive ability of polymorphonuclear leukocytes in paracoccidioidomycosis. (1980) (70)
Studies on human polymorphonuclear leukocyte enzymes. I. Assay of acid hydrolases and other enzymes. (1973) (67)
The surface membrane of Leishmania. I. The effects of lectins on different stages of Leishmania braziliensis. (1975) (66)
Physicochemical characteristics of the glycosaminoglycan-lysosomal enzyme interaction in vitro. A model of control of leucocytic lysosomal activity. (1976) (65)
Results of a double blind study of the influence of thalidomide on the lepra reaction. (1969) (62)
Intermediate or chronic cutaneous leishmaniasis: leukocyte immunophenotypes and cytokine characterisation of the lesion (2002) (62)
Progressive, atrophying, chronic granulomatous dermohypodermitis. Autoimmune disease? (1973) (62)
Immunological significance of Mycobacterium leprae cell walls. (1988) (60)
Epidemiological aspects of human and canine visceral leishmaniasis in Venezuela. (2003) (58)
Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG. I: Skin-test reactivity, T-cell proliferation and interferon-gamma production. (1994) (58)
Serum levels of tumor necrosis factor in patients with American cutaneous leishmaniasis. (1993) (57)
DISSEMINATED CUTANEOUS LEISHMANIASIS; INNOCULATION TO LABORATORY ANIMALS, ELECTRON MICROSCOPY AND FLUORESCENT ANTIBODIES STUDIES. (1965) (54)
Cotton rats (Sigmodon hispidus) and black rats (Rattus rattus) as possible reservoirs of Leishmania spp. in Lara State, Venezuela. (2002) (53)
Specific IgG antibody responses may be used to monitor leprosy treatment efficacy and as recurrence prognostic markers (2011) (50)
Elimination of Mycobacterium leprae subsequent to local in vivo activation of macrophages in lepromatous leprosy by other mycobacteria. (1974) (50)
Immunological changes observed in indeterminate and lepromatous leprosy patients and Mitsuda-negative contacts after the inoculation of a mixture of Mycobacterium leprae and BCG. (1979) (50)
IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy. (1991) (49)
Preliminary taxonomic studies on the leprosy bacillus. (1975) (49)
Canine visceral leishmaniasis on Margarita Island (Nueva Esparta, Venezuela). (2000) (48)
BCG vaccination protects against leprosy in Venezuela: a case-control study. (1993) (47)
T-cell subpopulations, expression of interleukin-2 receptor, and production of interleukin-2 and gamma interferon in human American cutaneous leishmaniasis (1988) (45)
Immunotherapy with live BCG plus heat killed Leishmania induces a T helper 1-like response in American cutaneous leishmaniasis patients. (2000) (44)
Characterization of Mycobacterium leprae cell wall-associated proteins with the use of T lymphocyte clones. (1989) (44)
Differing antibody IgG isotypes in the polar forms of leprosy and cutaneous leishmaniasis characterized by antigen‐specific T cell anergy (1995) (44)
Clinical Trial with Clofazimine for Treating Erythema Dyschromicum Perstans Evaluation of Cell‐Mediated Immunity (1989) (42)
Mononuclear cell subpopulations and infiltrating lymphocytes in erythema dyschromicum perstans and vitiligo. (1987) (42)
Vaccine development. On relating immunology to the Third World: some studies on leprosy. (1989) (39)
The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis. (2008) (39)
Leishmania braziliensis causing visceral leishmaniasis in a patient with human immunodeficiency virus infection, identified with the aid of the polymerase chain reaction. (1993) (39)
Cell‐mediated immunity in localized cutaneous leishmaniasis patients before and after treatment with immunotherapy or chemotherapy (1989) (38)
Association of HLA specificity LB-E12 (MB1, DC1, MT1) with lepromatous leprosy in a Venezuelan population. (2008) (37)
Atypical cutaneous leishmaniasis in Central America: possible interaction between infectious and environmental elements. (2005) (37)
DISSEMINATED ANERGIC CUTANEOUS LEISHMANIASIS. (1962) (35)
Biology of Leishmania and Leishmaniasis (1988) (35)
The development of a vaccination model using two microorganisms and its application in leprosy and leishmaniasis. (1986) (33)
Study of the antibody response against Mycobacterium tuberculosis antigens in Warao Amerindian children in Venezuela. (2004) (33)
Immunocytochemical characterization of immune cells in lesions of American cutaneous leishmaniasis using novel T cell markers. (1991) (33)
The Kellersberger Memorial Lecture: leprosy and leishmaniasis similar clinical-immunological-pathological models. (1974) (32)
Studies on plating efficiency and estimation of viability of suspensions of Paracoccidioides brasiliensis yeast cells (1980) (31)
ELECTRON MICROSCOPE STUDY OF MYCOBACTERIUM LEPRAE AND ITS ENVIRONMENT IN A VESICULAR LEPROUS LESION (1962) (31)
Immune response in healthy volunteers vaccinated with BCG plus killed leishmanial promastigotes: antibody responses to mycobacterial and leishmanial antigens. (1994) (30)
Leishmaniasis: Immunological and clinical aspects and vaccines in Venezuela. (1996) (30)
The effect of fresh serum on the leptomonads of Leishmania. I. Preliminary report. (1968) (29)
A test for the determination of competency in clearing bacilli in leprosy patients. (1972) (28)
Fabry's disease: normal α‐galactosidase activity and urinary‐sediment glycosphingolipid levels in two obligate heterozygotes (1973) (28)
Interruption of Onchocerca volvulus transmission in Northern Venezuela (2013) (28)
Serologic follow-up of IgG responses against recombinant mycobacterial proteins ML0405, ML2331 and LID-1 in a leprosy hyperendemic area in Venezuela. (2012) (26)
Delayed-type hypersensitivity and immunoglobulin E in American cutaneous leishmaniasis (1982) (26)
Disseminated anergic American leishmaniasis; report of three cases of a type clinically resembling lepromatous leprosy. (1957) (26)
Albendazole in the treatment of onchocerciasis: double-blind clinical trial in Venezuela. (1992) (25)
Molecular epidemiology of cutaneous leishmaniasis in Venezuela. (2002) (25)
Isolation of Leishmania infantum, zymodeme MON-1 from canine and human visceral leishmaniasis on Margarita Island, Venezuela. (2001) (25)
Mycolic Acids from “Noncultivable” Mycobacteria (1974) (25)
Prevalence of Helicobacter pylori infection in Warao lineage communities of Delta Amacuro State, Venezuela. (2003) (24)
Studies on human polymorphonuclear leukocyte enzymes. II. Comparative study of the physical properties of primary and specific granules. (1973) (23)
Characterization and properties of α-d-mannosidase of human polymorphonuclear leucocytes (1973) (23)
Epidemiological and immunological aspects of human visceral leishmaniasis on Margarita Island, Venezuela. (2002) (23)
Adhesion molecules in lesions of American cutaneous leishmaniasis (1994) (22)
Coexistence of two species of Leishmania in the digestive tract of the vector Lutzomyia ovallesi. (1994) (22)
Treatment of diffuse cutaneous leishmaniasis with miltefosine: a case report (2006) (21)
Cutaneous leishmaniasis in Tachira State, Venezuela. (1994) (21)
A simple method for the differentiation of Mycobacterium leprae from other mycobacteria through routine staining technics. (1972) (21)
Vaccination in leprosy--observations and interpretations. (1980) (20)
Visceral leishmaniasis due to a Leishmania variant that shares kinetoplast DNA sequences with Leishmania braziliensis and Leishmania mexicana in a patient infected with human immunodeficiency virus: identification of the Leishmania species with use of the polymerase chain reaction. (1995) (20)
The cutaneous lesion in American leishmaniasis: leukocyte subsets, cellular interaction and cytokine production. (1993) (19)
ELECTRON MICROSCOPE STUDY OF CUTANEOUS NERVES IN LEPROSY. (1963) (18)
Leprosy: Confirmation in the Armadillo (1974) (18)
In situ detection of amastigotes in American cutaneous leishmaniasis, using monoclonal antibodies. (1986) (18)
Gamma interferon production induced by antigens in patients with leprosy and American cutaneous leishmaniasis. (1987) (18)
Investigations related to the development of a leprosy vaccine. (1983) (18)
Studies on human polymorphonuclear leukocyte enzymes IV. Intracellular distribution and properties of α-l-fucosidase (1974) (17)
Leukocytic enzyme differences between the clinical forms of malnutrition. (1973) (17)
Polymorphonuclear activation in leprosy. I. Spontaneous and endotoxin-stimulated reduction of nitroblue tetrazolium: effects of serum and plasma on endotoxin-induced activation. (1975) (17)
Significance of neutrophil activation in reactional lepromatous leprosy: effects of thalidomide in vivo and in vitro. Activation in adjuvant disease. (1978) (17)
New method for estimating digestion of Paracoccidioides brasiliensis by phagocytic cells in vitro (1979) (17)
Leishmania species: comparative ultrastructure of experimental nodules and diffuse human cutaneous lesions in American leishmaniases. (1983) (17)
Discovery of a new onchocerciasis focus in Venezuela. (1977) (16)
Immunotherapy and immunoprophylaxis of leprosy. (1983) (16)
Cutaneous leishmaniasis in mice: resistance to glucan immunotherapy, either alone or combined with chemotherapy. (1982) (16)
Serological patterns and specificity in American cutaneous leishmaniasis. (1988) (16)
Heterogeneity of acid phosphatase activity in human polymorphonuclear leukocytes. (1973) (16)
Autoimmune diseases and thalidomide. II. Adjuvant disease, experimental allergic encephalomyelitis and experimental allergic neuritis of the rat. (1974) (15)
Antibody response in children infected with Giardia intestinalis before and after treatment with Secnidazole. (2009) (15)
Effectiveness of dapsone in Behçet's disease (1984) (14)
Sinefungin as treatment for American Leishmania in sensitive BALB/c and resistant C57BL/6 mice. (1990) (14)
Immunological characteristics of the armadillo, Dasypus sabanicola. (1976) (14)
UNILATERAL DINITROCHLOROBENZENE IMMUNOPATHY OF RECALCITRANT WARTS (1978) (14)
APPLYING THE INDIRECT IMMUNOFLUQRESCENCY TEST TO THE STUDY OF AMERICAN CUTANEOUS LEISHMANIASIS (1969) (14)
Immunological correlates of cure in the first American cutaneous leishmaniasis patient treated by immunotherapy in Argentina. A case report. (2011) (14)
Autologous tumor lysate/Bacillus Calmette–Guérin immunotherapy as an adjuvant to conventional breast cancer therapy (2015) (14)
Thalidomide therapy in the lepra reaction. (1967) (14)
Leukocyte subsets in the granulomatous response produced after inoculation with Mycobacterium leprae-BCG in lepromatous patients. (1988) (13)
Some considerations regarding the immunology of leprosy. (1971) (13)
Naturally acquired leprosy-like disease in the nine-banded armadillo (Dasypus novemcinctus): reactions in leprosy patients to lepromins prepared from naturally infected armadillos. (1977) (12)
Ectopic skin lesions produced by Schistosoma mansoni. (1973) (12)
Lymphocyte transformation with phytomitogens in leprosy. (1972) (12)
Antigen-specific immunodeficiency and its relation to the spectrum of American cutaneous leishmaniasis. (1993) (12)
A study of antibody response in leprosy. (1969) (12)
Hematologic values among Warao indians with tuberculosis from the Orinoco Delta of Venezuela. (2003) (12)
Tests with three antigens in leprosy-endemic and non-endemic areas. (1975) (12)
The effects of adrenocorticotropic hormone (ACTH) in lepromatous lepra reaction. (1951) (12)
[Results of the epidemiological investigations on histoplasmosis, coccidioidomycosis and tuberculosis carried out in various regions of Venezuela]. (1961) (11)
A follow-up study of multibacillary Hansen's disease patients treated with multidrug therapy (MDT) or MDT + immunotherapy (IMT). (1997) (11)
Immunosuppression and cellular immunity reactions in leprosy patients treated with a mixture of Mycobacterium leprae and BCG. (1987) (11)
Intermediate cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis successfully treated with fluconazole (2014) (11)
Studies of leprosy in the German ethnic group of Colonia Tovar, Venezuela. V. The morbidity rates in BCG-vaccinated and unvaccinated groups during five years. (1956) (10)
Molecular approaches applied to the epidemiology of leishmaniasis in Venezuela. (1993) (10)
Multiple idiopathic hemorrhagic sarcoma of Kaposi; histopathologic study. (1947) (10)
Immunological reactions in onchocerciasis. (1970) (10)
Lepromin and tuberculin tests in Venezuelan leprosy foci; induction of lepromin reactivity by BCG vaccination. (1954) (9)
Thalidomide activity in experimental Arthus and anaphylactic reactions. (1971) (9)
A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy. (1994) (8)
IMMUNOTHERAPY OF AMERICAN CUTANEOUS LEISHMANIASIS (1989) (8)
[A new disease of the leishmaniasis group: leishmaniasis cutis diffusa]. (1960) (8)
[Tuberculosis in subjects under 15 years of age in the population of Warao in Venezuela]. (2002) (8)
Serological and immunohistological studies on lepromatous leprosy. (1981) (8)
Spheroidal bodies and globi of human leprosy. (1973) (8)
Inorganic particles in the skin of inhabitants of volcanic areas of Central America: their possible immunomodulatory influence in leishmaniasis and leprosy. (2006) (8)
Changes in the lepromin and tuberculin reactions of lepromin-negative leprosy patients after vaccination with BCG. (1952) (8)
New organelle observed in Leishmania brasiliensis. (1973) (7)
Specificity of the 48-hour reaction to Mitsuda antigen. Use of a soluble antigen from human and armadillo lepromin. (1975) (7)
ELECTRON MICROSCOPIC STUDY OF BORDERLINE LEPROSY. (1963) (7)
The methylene blue test in leprosy. (1960) (7)
Field epidemiology: Molecular epidemiology of cutaneous leishmaniasis in Venezuela (2002) (7)
Serologic response to mycobacterial proteins in hansen's patients during multidrug treatment. (1999) (7)
N.B.T. test in lepromatous leprosy. (1973) (6)
Germicidal activity of a polyenzymic system on pathogenic protozoa in vitro. (1975) (6)
Autoimmune diseases and thalidomide. I. Experimental allergic encephalomyelitis and experimental allergic neuritis of the guinea pig. (1972) (6)
The Mitsuda test in non-leprous persons in a non-endemic country. (1947) (6)
Cutaneous Leishmaniasis: The Clinical and Immunopathological Spectrum in South America (2008) (6)
Parasitic oligosaccharide residues recognized by patients with mucocutaneous and localized cutaneous leishmaniasis. (1992) (6)
Loss of infectivity of mycobacterial and protozoal exoplasmic parasites after exposure in vitro to the polyenzymic cocktail 'PIGO'. (1976) (6)
Identification of the noncultivable pathogenic mycobacteria M. leprae and M. lepraemurium. (1968) (6)
Cojedes: a leprosy hyperendemic state (2012) (6)
On the acid phosphatase isoenzymes existing in American Leishmania promastigotes. (1989) (6)
Rhinoscleroma. Review and presentation of a case. (1961) (5)
Susceptibility of Simulium metallicum to infection with Onchocerca volvulus in Venezuela. (1984) (5)
Experimental inoculation of human leprosy in laboratory animals. I. Clinical, bacteriologic, and histopathologic study. (1962) (5)
Some observations on borderline leprosy. (1956) (5)
In vitro activation of neutrophils by suspensions of Mycobacterium leprae. (1979) (5)
Treatment of granuloma inguinale with triacetyloleandomycin. Report of a case. (1961) (5)
Therapy of leprosy. (1970) (5)
Studies on cellular immunity in leprosy. I. Lysosomal enzymes. (1970) (5)
The Mantoux and Mitsuda reactions in hamsters and guinea-pigs before and after vaccination with BCG. (1955) (5)
Mechanisms of immunological unresponsiveness in the spectra of leprosy and leishmaniasis. (1988) (5)
Consensus development statement on the chemotherapy of leprosy. American Leprosy Missions International and G. W. Long Hansen's Disease Center. (1992) (5)
Fighting leprosy and other endemic diseases. (2002) (4)
Experimental inoculation of human leprosy in laboratory animals. II. Electron microscope study. (1962) (4)
Detection of antibodies toward secreted mycobacterial antigen 85 in untreated leprosy patients' sera. (1999) (4)
An investigation of leprosy in the German ethnic group of Colonia Tovar in Venezuela. IV. Clinical findings and variations in the Mantoux and Mitsuda reactions observed during five years after BCG vaccination of Mitsuda-negative contacts. (1956) (4)
Experimental infections of three Guatemalan blackfly species with north Venezuelan Onchocerca volvulus (1986) (4)
Density of epidermal Langerhans cells in psoriasis patients treated with an aromatic retinoid (RO 10-9359). An immunoperoxidase study using anti-T6 and anti-Ia monoclonal antibodies. (1986) (4)
Applying the indirect immunofluorescency test to the study of American cutaneous leishmaniasis. (1969) (4)
Cross reactivity of Mycobacterium laprae and BCG. A report on further studies. (1972) (3)
Histochemical identification of non-culturable mycobacteria (M. leprae and M. lepramurium) (1973) (3)
[Immunotherapy of disseminated common warts with dinitrochlorobenzene]. (1976) (3)
Thalidomide in Lepra Reaction and in Hansen’s Disease (1968) (3)
[Diffuse tegumental leishmaniasis; new clinicopathological & parasitic entity]. (1958) (3)
Analysis of vaccines prepared from armadillo-derived M. leprae; results of an inter-laboratory study coordinated by the World Health Organization. Immunology of Mycobacterial Diseases (IMMYC) Steering Committee, World Health Organization. (1995) (3)
Preliminary study of cellular immunity to Mycobacterium leprae protein in contacts and leprosy patients. (1992) (3)
Studies on human polymorphonuclear leukocyte enzymes. 3. Differential activation of primary and specific granules by phospholipase C and deoxycholate. (1974) (3)
EXPERIMENTAL INOCULATION OF HUMAN LEPROSY IN LABORATORY ANIMALS. 3. (1964) (3)
The Lepromin Test in Tuberculous Persons in a Non-Endemic Area. (1944) (3)
Studies on the effect of serum and proteins on in vitro-induced neutrophil activation. (1978) (3)
The histochemistry of armadillo skin. (1975) (3)
[Study of immune response in Warao children from communities with high tuberculosis prevalence]. (2003) (3)
Thiosemicarbazone (TB-1) in the Treatment of Leprosy. Preliminary Communication. (1950) (3)
Ethics of HIV trials (1997) (3)
[Increase in nitric oxide concentrations in serum and mononuclear cell cultures from patients with Type II reaction state of Hansen's disease]. (2003) (3)
POSITIVITY OF THE METHYLENE BLUE TEST IN XANTHOMATOSIS. (1963) (3)
Immunological reactions to mycobacterial proteins in the spectrum of leprosy. (1997) (3)
Serotypes of Leishmania mexicana and L. braziliensis defined by enriched polyclonal sera, with particular reference to Venezuelan isolates. (1986) (2)
INFECTIONS PRODUCED IN HAMSTERS WITH THE HUMAN LEPROSY BACILLUS: A CRITIQUE OF RECENT STUDIES. (1964) (2)
[Some immunological aspects in the reaccional states of Hansen disease]. (2005) (2)
Studies on the Reticulum in the Different Types of Leprosy. (1948) (2)
General ideas concerning a vaccine against leprosy: a basis for discussion during the Eleventh International Leprosy Congress. (1978) (2)
Electron Microscope Study of Xanthoma Cells in a Lepromatous Leprosy Lesion. (1961) (2)
Immunotherapy and immunoprophylaxis of leprosy. (2000) (2)
Indigenous leprosy in the armadillo Dasypus novemcinctus. (1978) (2)
Serologic recognition of low molecular weight mycobacterial protein fractions in lepromatous patients with type II reactions (ENL). (2005) (2)
Leprosy: Bacterial, Pathological, Immunological and Immunopathological Aspects (1989) (2)
[COMMENTS ON THE STATUS OF MYCOBACTERIA IN MODERN TAXONOMY]. (1964) (1)
Proceedings: Physical properties of primary and specific granules of polymorphonuclear leukocytes. (1973) (1)
Thiosemicarbazone (TB-1) in the treatment of preliminary communication. (1950) (1)
[EXPERIMENTAL INOCULATION OF LABORATORY ANIMALS WITH HUMAN LEPROSY]. (1964) (1)
Insights into Immunoregulation and Pathogenesis from a Third World Disease (1989) (1)
The campaign against leprosy in Venezuela. (1960) (1)
Immunological aspects of leishmaniasis. (1977) (1)
Interruption of Onchocerca volvulus transmission in Northern Venezuela (2013) (1)
Non-Enzymatic Reduction of Methylene Blue and 2,6-Dichlorophenolindophenol by Reduced Di- and Triphosphopyridine Nucleotides (1964) (1)
[A clinical constelation in disuse: vitiligo, mastocytosis of the bone marrow, circulating heparinoid, chronic leg ulcer, hypoalbuminemia, ulcerative colitis and hepatic fibrosis]. (1977) (1)
[The methylene blue test in the exploration of the leprosy patient]. (1961) (1)
The Skin Immune System across the Spectrum of American Cutaneous Leishmaniasis (1996) (1)
[Experimental inoculation of animals with Mycobacterium leprae]. (1961) (1)
Evaluation of "chemical isolation" in 1,168 leprosy patients' homes. (1975) (1)
[Serological and cellular reactivity to mycobacterial proteins in Hansen's disease]. (2010) (1)
Dermal exudate macrophages: induction in dermal chambers and response to lymphokines. (1975) (1)
[Immune response of Hansen's disease. Review]. (2009) (1)
IgE in leprosy; effect of a Mycobacterium leprae-BCG vaccine. (1983) (1)
Subcutaneous abscesses caused by T. rubrum. (1970) (1)
The surface membrane of Leishmania. II. Energy dependent agglutination of Leishmania braziliensis by concanavalin A. (1977) (1)
[Diffuse cuttaneous leishmaniasis. A new clinicopathological and parasitic entity]. (1959) (1)
Trypanosoma (Herpetosoma) lewisi in Rattus spp from La Matica, Lara State, Venezuela and the possible relationship with zoonotic diseases (2003) (1)
Kinetic and electrophoretic studies on the cyanide insensitive NADH diaphorase of human polymorphonuclear leukocytes. (1976) (1)
Antinuclear antibodies: study by liver imprint technique. (1973) (1)
Molecular Approaches to Developing a Vaccine for Leprosy (1989) (1)
[The problem of leprosy]. (1961) (1)
[Epidemiologic importance of age groups in colonies of the Simulium metallicum (Diptera: Simullidae) in Venezuela]. (1976) (0)
[Leprosy among Germans of Colonia Tovar, Venezuela]. (1952) (0)
Subcutaneous abscesses caused by Trichophyton rubrum. (1970) (0)
Dermal exudate macrophages. Induction in dermal chambers and response to lymphokines. (1975) (0)
Progress report from the PAHO/WHO International Center for Training and Research in Leprosy and Related Diseases (1975) (0)
Early Forms of Pinta. Clinical and Histológical Observations. (1950) (0)
Leishmaniasis Tegumentaria Diffusa: a New Nosological Entity. (1958) (0)
Formation of methylene blue-lipid complexes. (1972) (0)
SUSCEPTIBILITY OF SIMULIUM METALLICUAI TO INFECTION WITH ONCHOCERCA VOLVULUS IN VENEZUELA l (1984) (0)
[Epidemiological aspects of leprosy in Venezuela]. (1954) (0)
[REHABILITATION IN PUBLIC HEALTH PROGRAMS]. (1963) (0)
The development of an active vaccine against leprosy. (1979) (0)
Evaluation of the Leprosy Control Program of the Philippines. I. Methods. II. Application and Manner of Analysis. (1962) (0)
Treatment of S. American blastomycosis with a new antibiotic. (1966) (0)
[Not Available]. (1948) (0)
[Rate of natural infection of Simulium metallicum (Diptera:Simuliidae) by evolved forms of Onchocerca volvulus in Venezuela]. (1977) (0)
Regarding analysis of vaccines. (1995) (0)
Pyridine extraction of M. leprae. (1979) (0)
[Leprosy in the Colonia Tovar. I. Prevalence in the German ethnic group]. (1954) (0)
Immunological significance of Mycobacterium leprae cell walls (cell-mediated immunity/delayed-type hypersensitivity/peptidoglycan-protein complex/leprosy/precursor frequency analysis) (2016) (0)
[Jonctum in chronic ulcers of the lower extremities. Double blind study]. (1974) (0)
The molecular epidemiology of tuberculosis in Caracas, Venezuela, with IS6110 DNA fingerprinting. (2001) (0)
Tropical medicine rounds Cojedes : a leprosy hyperendemic state (2012) (0)
SHORT COMMUNICATION - Isolation of Leishmania infantum ,Zymodeme MON-1 from Canine and Human Visceral Leishmaniasis onMargarita Island, Venezuela (2001) (0)
The “mesosome” of Mycobacterium leprae. The cellular division. (1998) (0)
Editorial by the President of the International Leprosy Association. (1973) (0)
[Immunologic answer in onchocerciasis]. (1967) (0)
IV BRAZILIAN HANSEN'S DISEASE CONGRESS rto Alegre, october, 29th to november, 1st 1982 PRESIDENT OF HONOR: FranciscoEduardoRabello PRESIDENT: CésarD.Y.Bernardi SECRETARY: JairFerreira EXECUTIVESECRETARY: JoséGrossaNeto Treasure: (2008) (0)
ERITEMA DISCROMICO PERSTANS (2015) (0)
Study of Reticulum in the Different Types of Leprosy. (1949) (0)
Effect of interleukin-1 (IL-1) and IL-2 on lymphocytes from patients with leprosy. (1987) (0)
Erratum to: Autologous tumor lysate/Bacillus Calmette–Guérin immunotherapy as an adjuvant to conventional breast cancer therapy (2016) (0)
Larval stages and adult parasites of filarie from dasypus sabanicola (armadillo local). Preliminary report (1983) (0)
[THE EPIDEMIOLOGY OF LEPROSY IN VENEZUELA]. (1964) (0)
[Mycetoma, chromomycosis, sporotrichosis and Jorge Lobo disease]. (1961) (0)
Histology and Histopatholog y Density of epidermal Langerhans cells in psoriasis patients treated with an aromatic retinoid ( RO 10-9359 ) . An immunoperoxidase study using anti-T 6 and anti-la monoclonal antibodies (2010) (0)
Development of a mixture of mycobacterium leprae plus BCG as a vaccine against leprosy Its application in immunotherapy and immunoprophilaxis (1982) (0)
PRELIMINARY TAXONOMIC STUDIESON THE LEPROSY BACILLUS (1975) (0)
Epidemiological Data on the Focus of Leprosy in Colonia Tovar, State of Aragua. (1964) (0)
Comparative study of the 48-hour response to soluble antigens obtained from human and armadillo leprosy material in lepromatous leprosy patients and normal persons, contacts of leprosy patients. (1976) (0)
Experimental Studies with a Strain of Leishmania brasiliensis from a Case of Disseminated Lepromatous-like Cutaneous Leishmaniasis. (1949) (0)
Chronic allergic encephalomyelitis of the guinea pig: effects of maternal sensitization on the offspring. (1976) (0)
Curriculum: Jacinto Convit (2015) (0)
Population studies on Lutzomyia panamensis and Lu. gomezi, vectors of cutaneous leishmaniasis in Venezuela. (1981) (0)
Studies on Leprosy in an Ethnic Group of German Origin in Colonia Tovar, Venezuela. (1952) (0)
[Leprosy in the Colonia Tovar. II. Lepromin and tuberculin reactions in the German ethnic group]. (1954) (0)
Characterization and properties of alpha-D-mannosidase of human polymorphonuclear leucocytes. (1973) (0)
The methylene blue test in experimental granulomas. (1972) (0)
Treatment of Paracoccidioidomycosis by a New Antibiotic. (1966) (0)
A message from the president. On the International Leprosy Association. (1970) (0)
In vitro interaction of Acantamoeba castellani with Leishmania brasiliensis. (1988) (0)
Gelatinase activity in Mycobacterium bovis protein extract. (2002) (0)
[Anti-Leishmania monoclonal antibodies of hybridoma origin]. (1986) (0)
Notes on the fecundity of several Central and South American blackflies (1987) (0)
Still Learning from Leprosy (1993) (0)

This paper list is powered by the following services:

Other Resources About Jacinto Convit

en.wikipedia.org

What Schools Are Affiliated With Jacinto Convit?

Jacinto Convit is affiliated with the following schools:

Image Attributions

Image Source for Jacinto Convit